J Korean Endocr Soc.  2009 Dec;24(4):247-253. 10.3803/jkes.2009.24.4.247.

Pituitary Apoplexy in Korea - Characteristics, Treatment Options and Outcomes

Affiliations
  • 1Department of Internal Medicine, Seoul National University College of Medicine, Korea.
  • 2Department of Internal Medicine, Eulji University College of Medicine, Korea.

Abstract

BACKGROUND
Reports on pituitary apoplexy in Korea are limited. There are two treatment options for pituitary apoplexy - surgical decompression and conservative management. In this study, we examined clinical presentation and outcomes following different therapies in Korean patients with pituitary apoplexy. METHODS: Clinical data and treatment outcomes from 52 patients with pituitary apoplexy who visited Seoul National University Hospital between January 1992 and June 2008 were reviewed retrospectively. Patients were divided into 2 groups according to management options (a surgery group vs. a conservative management group) and their outcomes were compared. For patients who underwent surgery due to neurological symptoms, outcomes were compared between early and late surgery groups. RESULTS: Headache (73.1%) was the most common presenting symptom, and more than half of the patients were reported to have visual symptoms. The most common type of pathology was a nonfunctioning pituitary adenoma (67.3%). Nine patients received conservative management and 43 underwent surgical decompression. Their recovery from neurological and endocrinological abnormalities were similar. Among patients who showed neurological symptoms, 9 underwent surgery within 1 week of symptom onset and 24 underwent surgery after 1 week. There was no significant difference between outcomes of early and late surgery groups except recovery from impaired visual deficit was greater in the late surgery group. CONCLUSION: Patients with pituitary apoplexy in Korea show similar clinical features as similar patients in other countries. In our study, there was no significant difference between clinical outcomes of the surgery group and the conservative treatment group.

Keyword

observation; pituitary apoplexy; surgery; treatment outcome

MeSH Terms

Decompression, Surgical
Headache
Humans
Korea
Pituitary Apoplexy
Pituitary Neoplasms
Retrospective Studies
Treatment Outcome

Reference

1. Semple PL, Webb MK, de Villiers JC, Laws ER Jr. Pituitary apoplexy. Neurosurgery. 2005. 56:65–72.
2. Lee JH, Kim JH, Moon KS, Joo SP, Lee JK, Kim SH. Pituitary apoplexy: Surgical experience with 16 patients. J Korean Neurosurg Soc. 2007. 42:83–88.
3. Kim JK, Park BJ, Cho KT, Lee SK, Cho MK, Kim YJ. Surgical outcomes of pituitary apoplexy. J Korean Neurosurg Soc. 2005. 38:450–455.
4. Nawar RN, AbdelMannan D, Selman WR, Arafah BM. Pituitary tumor apoplexy: a review. J Intensive Care Med. 2008. 23:75–90.
5. Maccagnan P, Macedo CL, Kayath MJ, Nogueira RG, Abucham J. Conservative management of pituitary apoplexy: a prospective study. J Clin Endocrinol Metab. 1995. 80:2190–2197.
6. Lubina A, Olchovsky D, Berezin M, Ram Z, Hadani M, Shimon I. Management of pituitary apoplexy: clinical experience with 40 patients. Acta Neurochir (Wien). 2005. 147:151–157.
7. Ayuk J, McGregor EJ, Mitchell RD, Gittoes NJ. Acute management of pituitary apoplexy-surgery or conservative management? Clin Endocrinol (Oxf). 2004. 61:747–752.
8. Sibal L, Ball SG, Connolly V, James RA, Kane P, Kelly WF, Kendall-Taylor P, Mathias D, Perros P, Quinton R, Vaidya B. Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases. Pituitary. 2004. 7:157–163.
9. Gruber A, Clayton J, Kumar S, Robertson I, Howlett TA, Mansell P. Pituitary apoplexy: retrospective review of 30 patients-is surgical intervention always necessary? Br J Neurosurg. 2006. 20:379–385.
10. Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CB, Wass JA. Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol (Oxf). 1999. 51:181–188.
11. Semple PL, Jane JA Jr, Laws ER Jr. Clinical relevance of precipitating factors in pituitary apoplexy. Neurosurgery. 2007. 61:956–961.
12. Fuchs S, Beeri R, Hasin Y, Weiss AT, Gotsman MS, Zahger D. Pituitary apoplexy as a first manifestation of pituitary adenomas following intensive thrombolytic and antithrombotic therapy. Am J Cardiol. 1998. 81:110–111.
13. Bonicki W, Kasperlik-Załuska A, Koszewski W, Zgliczyński W, Wisławski J. Pituitary apoplexy: endocrine, surgical and oncological emergency. Incidence, clinical course and treatment with reference to 799 cases of pituitary adenomas. Acta Neurochir (Wien). 1993. 120:118–122.
14. Bills DC, Meyer FB, Laws ER Jr, Davis DH, Ebersold MJ, Scheithauer BW, Ilstrup DM, Abboud CF. A retrospective analysis of pituitary apoplexy. Neurosurgery. 1993. 33:602–608.
15. Lee SI, Lee JY, Yang HD, Kwon JB, Lee SS, Park KC, Kim SM. Spontaneous resolution of pituitary apoplexy: Report of 4 cases. J Korean Neurol Assoc. 2000. 18:779–782.
16. Watt A, Pobereskin L, Vaidya B. Pituitary apoplexy within a macroprolactinoma. Nat Clin Pract Endocrinol Metab. 2008. 4:635–641.
17. Muthukumar N, Rossette D, Soundaram M, Senthilbabu S, Badrinarayanan T. Blindness following pituitary apoplexy: timing of surgery and neuro-ophthalmic outcome. J Clin Neurosci. 2008. 15:873–879.
18. Kaplan B, Day AL, Quisling R, Ballinger W. Hemorrhage into pituitary adenomas. Surg Neurol. 1983. 20:280–287.
19. Onesti ST, Wisniewski T, Post KD. Clinical versus subclinical pituitary apoplexy: presentation, surgical management, and outcome in 21 patients. Neurosurgery. 1990. 26:980–986.
Full Text Links
  • JKES
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr